Literature DB >> 28546702

Efficacy of Sentinel Lymph Node Biopsy in Detecting Axillary Metastasis in Breast Cancer Using Methylene Blue.

Vipul V Nandu1, Milind S Chaudhari1.   

Abstract

Breast cancer is the leading malignancy and the second leading cause of cancer-related deaths. Axillary lymph node status is a very important prognostic factor in breast cancer patients; nodal evaluation is therefore a critical part of breast cancer management. Axillary lymph node dissection results in significant morbidity. Sentinel lymph node biopsy (SLNB) is being used in many centers to stage the axilla in planning axillary dissection management of patients and hence plays an important part in reducing morbidity among patients with carcinoma breast. The objectives of this paper is to study the (1) efficacy of sentinel lymph node biopsy in detecting axillary metastasis, (2) location of sentinel lymph node in the axilla, (3) rate of involvement of sentinel lymph nodes, and (4) incidence of skip metastasis. Thirty-five patients with breast cancer with clinically node-negative axilla were selected for the study. Methylene blue dye was injected intralesional and perilesional 20 min prior to surgery. All patients underwent modified radical mastectomy with sentinel lymph node biopsy and axillary dissection and after pathological examination diagnostic statics, namely sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were computed. Sentinel lymph node was identified in all of these patients. Sixty percent patients had pathologically positive lymph nodes in the axilla. 90.48% patients of these had sentinel lymph nodes positive for malignant cells. Incidence of skip metastasis is 9.52%. 88.57% patients had sentinel lymph node mapped to level I lymph nodes. Sensitivity of SLNB is 90.48%, specificity is 85.71%, PPV of is 90.48%, NPV is 85.71%, and accuracy is 88.57%. Sentinel lymph node biopsy is an effective method of staging the axilla and deciding on axillary clearance in patients of carcinoma breast. Unnecessary axillary dissection and associated complications can be prevented in most of patients due to sentinel lymph node biopsy.

Entities:  

Keywords:  Axillary lymph node dissection; Breast cancer; Efficacy; Sentinel lymph node biopsy

Year:  2016        PMID: 28546702      PMCID: PMC5427042          DOI: 10.1007/s13193-016-0616-z

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  10 in total

1.  I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.

Authors:  W S Halsted
Journal:  Ann Surg       Date:  1894-11       Impact factor: 12.969

2.  Technical details of intraoperative lymphatic mapping for early stage melanoma.

Authors:  D L Morton; D R Wen; J H Wong; J S Economou; L A Cagle; F K Storm; L J Foshag; A J Cochran
Journal:  Arch Surg       Date:  1992-04

Review 3.  Axillary dissection in the context of the biology of lymph node metastases.

Authors:  J E Gervasoni; C Taneja; M A Chung; B Cady
Journal:  Am J Surg       Date:  2000-10       Impact factor: 2.565

4.  Sentinel lymph node biopsy assessment using intraoperative imprint cytology in breast cancer patients: results of a validation study.

Authors:  Suryanarayana Deo; Atul Samaiya; Paresh Jain; Sonal Asthana; Mona Anand; Nootan K Shukla; Rajive Kumar
Journal:  Asian J Surg       Date:  2004-10       Impact factor: 2.767

5.  Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.

Authors:  J S Rietman; P U Dijkstra; J H B Geertzen; P Baas; J de Vries; W V Dolsma; J W Groothoff; W H Eisma; H J Hoekstra
Journal:  Ann Surg Oncol       Date:  2004-10-15       Impact factor: 5.344

6.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

7.  Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

Authors:  R R Turner; D W Ollila; D L Krasne; A E Giuliano
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

8.  Lower incidence but more aggressive behavior of right sided breast cancer in Pakistani women: does right deserve more respect?

Authors:  Nosheen Fatima; Maseeh Uz Zaman; Aamir Maqbool; Shaista H Khan; Nazia Riaz
Journal:  Asian Pac J Cancer Prev       Date:  2013

9.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

Authors:  A E Giuliano; D M Kirgan; J M Guenther; D L Morton
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

10.  Sentinel lymphnode biopsy in early breast cancer using methylene blue dye and radioactive sulphur colloid - a single institution Indian experience.

Authors:  S P Somashekhar; S Zaveri Shabber; K Udupa Venkatesh; K Venkatachala; M M Vasan Thirumalai
Journal:  Indian J Surg       Date:  2008-07-24       Impact factor: 0.656

  10 in total
  6 in total

Review 1.  Evaluating the safety of oral methylene blue during swallowing assessment: a systematic review.

Authors:  Bina Tariq; Sorina R Simon; Walmari Pilz; Andra Maxim; Bernd Kremer; Laura W J Baijens
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-02       Impact factor: 2.503

2.  iTRAQ proteomics of sentinel lymph nodes for identification of extracellular matrix proteins to flag metastasis in early breast cancer.

Authors:  Sheetal Pathania; Mohd Imran Khan; Sabyasachi Bandyopadhyay; Suneet Shekhar Singh; Komal Rani; Tanvi Ramesh Parashar; Jnaneshwari Jayaram; Piyush Ranjan Mishra; Anurag Srivastava; Sandeep Mathur; Smriti Hari; Perumal Vanamail; Gururao Hariprasad
Journal:  Sci Rep       Date:  2022-05-22       Impact factor: 4.996

3.  Comparative study of two contrast agents for intraoperative identification of sentinel lymph nodes in patients with early breast cancer.

Authors:  Yan Sun; Ligang Cui; Shunmin Wang; Tan Shi; Yunxia Hao; Yutao Lei
Journal:  Gland Surg       Date:  2021-05

4.  Proteomics of Sentinel Lymph Nodes in Early Breast Cancer for Identification of Thymidylate Synthase as a Potential Biomarker to Flag Metastasis: A Preliminary Study.

Authors:  Sheetal Pathania; Mohd Imran Khan; Abhishek Kumar; Ashish Kumar Gupta; Komal Rani; Tanvi Ramesh Parashar; Jnaneshwari Jayaram; Piyush Ranjan Mishra; Anurag Srivastava; Sandeep Mathur; Smriti Hari; Gururao Hariprasad
Journal:  Cancer Manag Res       Date:  2020-06-23       Impact factor: 3.989

Review 5.  Current State of Breast Cancer Diagnosis, Treatment, and Theranostics.

Authors:  Arya Bhushan; Andrea Gonsalves; Jyothi U Menon
Journal:  Pharmaceutics       Date:  2021-05-14       Impact factor: 6.321

6.  Trends in Axillary Management of Early Breast Cancer: a Questionnaire-Based Pattern of Practice Survey for India.

Authors:  Sanjit Kumar Agrawal; Noopur Priya; Pooja Agarwal; Abhishek Sharma; Soumitra Shankar Datta; S V S Deo; Rosina Ahmed
Journal:  Indian J Surg Oncol       Date:  2021-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.